As of 2024-07-27, the Relative Valuation of Flexion Therapeutics Inc (FLXN) is (60.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.12 USD, the upside of Flexion Therapeutics Inc based on Relative Valuation is -761.8%.
The range of the Relative Valuation is (63.62) - (59.17) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.2x - 31.9x | 31.8x |
| Forward P/E multiples | 25.2x - 29.0x | 27.4x |
| Fair Price | (63.62) - (59.17) | (60.36) |
| Upside | -797.6% - -748.8% | -761.8% |
| Date | P/E |